Literature DB >> 26614241

Noninvasive Ventilation for the Emergency Physician.

Michael G Allison1, Michael E Winters2.   

Abstract

Noninvasive ventilation (NIV) improves oxygenation and ventilation, prevents endotracheal intubation, and decreases the mortality rate in select patients with acute respiratory failure. Although NIV is used commonly for acute exacerbations of chronic obstructive pulmonary disease and acute cardiogenic pulmonary edema, there are emerging indications for its use in the emergency department. Emergency physicians must be knowledgeable regarding the indications and contraindications for NIV in emergency department patients with acute respiratory failure as well as the means of initiating it and monitoring patients who are receiving it.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute respiratory failure; Bilevel positive airway pressure; Continuous positive airway pressure; High flow nasal cannula; Noninvasive ventilation

Mesh:

Year:  2016        PMID: 26614241     DOI: 10.1016/j.emc.2015.08.004

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  4 in total

1.  Early decrease of oxidative stress by non-invasive ventilation in patients with acute respiratory failure.

Authors:  Alessia Garramone; Roberto Cangemi; Emanuela Bresciani; Roberto Carnevale; Simona Bartimoccia; Elisa Fante; Marco Corinti; Marco Brunori; Francesco Violi; Giuliano Bertazzoni; Pasquale Pignatelli
Journal:  Intern Emerg Med       Date:  2017-09-15       Impact factor: 3.397

Review 2.  Non-invasive ventilation in the ED: Whom, When, How?

Authors:  Erkan Göksu; Deniz Kılıç; Süleyman İbze
Journal:  Turk J Emerg Med       Date:  2018-02-13

Review 3.  Noninvasive Ventilation and Oxygenation Strategies.

Authors:  Patrycja Popowicz; Kenji Leonard
Journal:  Surg Clin North Am       Date:  2022-02       Impact factor: 2.741

4.  Comparison of high-flow oxygen treatment and standard oxygen treatment in patients with hypertensive pulmonary edema.

Authors:  Kemal Şener; Mustafa Çalış; Zikret Köseoğlu; Sezai Sarı; Mustafa Polat; Durdu Mehmet Üzücek; Sadiye Yolcu
Journal:  Anatol J Cardiol       Date:  2020-10       Impact factor: 1.596

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.